Optimal dose selection accounting for patient subpopulations in a randomized Phase II trial to maximize the success probability of a subsequent Phase III trial

Fumihiro Takahashi, Satoshi Morita
  • Journal of Biopharmaceutical Statistics, February 2018, Taylor & Francis
  • DOI: 10.1080/10543406.2018.1428614
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: